Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Nature Communications
|
March 26, 2014
Ammonia as a case study for the spontaneous ionization of a simple hydrogen-bonded compound
Taras Palasyuk, Ivan Troyan, Mikhail Eremets, et al.
Gene
|
October 21, 2021
CRISPR-Cas9 mediated knockout of AnxA6 gene enhances influenza A virus replication in low-permissive HEK293FT cell line
Andrey Komissarov, Mariia Sergeeva, Evgenii Zhuravlev, et al.
Gynecologic Oncology
|
December 11, 2019
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer
Sarah B Gitto, Hyoung Kim, Stavros Rafail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
Sarah B Gitto, Margaret Whicker, Gareth Davies, et al.
Research Square
|
February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Frontiers in Immunology
|
November 29, 2023
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
Milena Kalaitsidou, Owen R Moon, Martina Sykorova, et al.
Nature Communications
|
April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim, Haineng Xu, Erin George, et al.
Nature Communications
|
July 3, 2025
Correlation between the dome-shaped superconducting phase diagram, charge order, and normal-state electronic properties in LaRu<sub>3</sub>Si<sub>2</sub>
KeYuan Ma, Igor Plokhikh, Jennifer N Graham, et al.
Iscience
|
July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancer
Haineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Nature Communications
|
March 26, 2014
Ammonia as a case study for the spontaneous ionization of a simple hydrogen-bonded compound
Taras Palasyuk, Ivan Troyan, Mikhail Eremets, et al.
Gene
|
October 21, 2021
CRISPR-Cas9 mediated knockout of AnxA6 gene enhances influenza A virus replication in low-permissive HEK293FT cell line
Andrey Komissarov, Mariia Sergeeva, Evgenii Zhuravlev, et al.
Gynecologic Oncology
|
December 11, 2019
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer
Sarah B Gitto, Hyoung Kim, Stavros Rafail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
Sarah B Gitto, Margaret Whicker, Gareth Davies, et al.
Research Square
|
February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Frontiers in Immunology
|
November 29, 2023
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
Milena Kalaitsidou, Owen R Moon, Martina Sykorova, et al.
Nature Communications
|
April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Haineng Xu, Erin George, David Gallo, et al.
Nature Communications
|
July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim, Haineng Xu, Erin George, et al.
Nature Communications
|
July 3, 2025
Correlation between the dome-shaped superconducting phase diagram, charge order, and normal-state electronic properties in LaRu<sub>3</sub>Si<sub>2</sub>
KeYuan Ma, Igor Plokhikh, Jennifer N Graham, et al.
Iscience
|
July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancer
Haineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Page
of 5